-
Symbol
-
TLSI on Nasdaq
-
Investment type
-
Equity / Common stock, $0.0001 par value
-
Latest Disclosed Shares Owned
-
2,987,881 shares
-
Security Ownership %
-
6%
Mats Wahlstrom ownership in TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI)
01 Aug 2025 - Mats Wahlstrom has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,987,881 shares of TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI).
This represents 6% ownership of the company.
In their previous filing dated 19 Dec 2024, Mats Wahlstrom had reported owning 2,797,437 shares, indicating an increase of +6.8%.
.